EN IT

AstraZeneca drops 11.2% in its confirmation week as sellers take control

AstraZeneca weekly technical analysis: the stock drops 11.2% in its confirmation week as sellers take control, momentum turns negative, and this swing trading setup now sits last among 60 open European buy signals.

AstraZeneca drops 11.2% in its confirmation week as sellers take control
Buy signal, first week closes in the red
AstraZeneca drops 11.2% in its confirmation week as sellers take control
July 10, 2026
Buy signal, first week closes in the red
Our view last week
A fresh buy signal fires on AstraZeneca, 1st among the 3 new Longs for European-UK stocks, with a signal strength of 52 out of 100: medium conviction, steady profile. The weekly structure is clean, structural moving averages aligned and price above the Ichimoku cloud, while the daily chart shows a double bottom in the 12,460 area with a 14% rebound. The stock is still 8.81% below its all-time high: a first attempt, outcome still open, cautious entry.
This week's summary
Last week AstraZeneca opened a fresh buy signal with strong credentials; this week's confirmation closed with an 11.2% plunge that flips the picture. Sellers dominated the last session in extreme fashion and price slid inside the weekly cloud: the first week's confirmation calls for exiting the position. Signal strength drops to 23 out of 100, and AstraZeneca stock sits last among the 60 open European buy signals.
Open BUY ·1st week from start ·EU-UK stocks ·T1 ★ See Gold version →
IQS Phase
36
ordinary
Signal Strength
23
low · fading
Sizing
MINIMUM
Ranking
#60 / 60
EU-UK stocks in progress
Trade P&L %
-11.22%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn